Senzime AB (publ)
STO:SEZI

Watchlist Manager
Senzime AB (publ) Logo
Senzime AB (publ)
STO:SEZI
Watchlist
Price: 4.615 SEK -2.02% Market Closed
Market Cap: kr725.6m

Relative Value

The Relative Value of one SEZI stock under the Base Case scenario is hidden SEK. Compared to the current market price of 4.615 SEK, Senzime AB (publ) is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SEZI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

SEZI Competitors Multiples
Senzime AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Senzime AB (publ)
STO:SEZI
731.1m SEK 8.1 -6 -7.7 -5.8
US
Abbott Laboratories
NYSE:ABT
189.6B USD 4.3 29.1 16.5 22.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
171B USD 17 59.8 45.5 55.1
US
Stryker Corp
NYSE:SYK
138.8B USD 5.5 42.9 21.7 26.3
IE
Medtronic PLC
NYSE:MDT
132.5B USD 3.8 27.8 15.6 22.5
US
Boston Scientific Corp
NYSE:BSX
115.7B USD 6 41.5 24.6 33.5
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD 2.7 35.1 12.8 21.9
DE
Siemens Healthineers AG
XETRA:SHL
46.4B EUR 2 22 12.5 17.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.8B USD 12 48.7 34.8 38.4
US
Edwards Lifesciences Corp
NYSE:EW
45.4B USD 7.7 33.2 23.6 25.8
US
Resmed Inc
NYSE:RMD
39B USD 7.2 26.2 18.5 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Senzime AB (publ)
STO:SEZI
Average EV/EBITDA: 22.6
Negative Multiple: -7.7
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.5
24%
1.9
US
Stryker Corp
NYSE:SYK
21.7
12%
1.8
IE
Medtronic PLC
NYSE:MDT
15.6
8%
1.9
US
Boston Scientific Corp
NYSE:BSX
24.6
22%
1.1
US
Becton Dickinson and Co
NYSE:BDX
12.8
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.5
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.8
11%
3.2
US
Edwards Lifesciences Corp
NYSE:EW
23.6
13%
1.8
US
Resmed Inc
NYSE:RMD
18.5
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Senzime AB (publ)
STO:SEZI
Average EV/EBIT: 28.4
Negative Multiple: -5.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.5
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.1
25%
2.2
US
Stryker Corp
NYSE:SYK
26.3
16%
1.6
IE
Medtronic PLC
NYSE:MDT
22.5
17%
1.3
US
Boston Scientific Corp
NYSE:BSX
33.5
32%
1
US
Becton Dickinson and Co
NYSE:BDX
21.9
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.6
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.4
11%
3.5
US
Edwards Lifesciences Corp
NYSE:EW
25.8
14%
1.8
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7